SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Dishman Pharmaceuticals & Chemicals

Dishman Pharmaceuticals & Chemicals

BSE: 532526 | NSE: DISHMAN | ISIN: INE353G01020 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Aug 28, 16:00
209.90
11.00 (+5.53%)
VOLUME 212,521
AVERAGE VOLUME
5-Day 221,330
10-Day 242,006
30-Day 259,123
VOLUME SHOCKER
5-Day 221,330
10-Day 242,006
30-Day 259,123
Prev. Close
198.90
Open Price
200.05
Bid PRICE (QTY.)
0.00 (2)
Offer PRICE (Qty.)
0.00 (101)
Today’s Low/High 200.05 214.55
52 Wk Low/High 102.80 233.80
LIVE
NSE
Aug 28, 16:01
209.95
11.20 (+5.64%)
VOLUME 1,358,382
AVERAGE VOLUME
5-Day 1,025,843
10-Day 1,123,322
30-Day 1,241,840
VOLUME SHOCKER
5-Day 1,025,843
10-Day 1,123,322
30-Day 1,241,840
Prev. Close
198.75
Open Price
201.70
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
209.95 (5774)
Today’s Low/High 201.15 214.40
52 Wk Low/High 102.55 233.75
Action in Dishman Pharmaceuticals & Chemicals

Dishman Pharma
Sentimeter

100%
BUY

100% of moneycontrol users recommend buying Dishman Pharma. What's your call on Dishman Pharma today?
Read Investor view

Consolidated
MARKET CAP (Rs Cr)
1,693.83
P/E
29.65
BOOK VALUE (Rs)
105.83
DIV (%)
60.00%
Market Lot
1
INDUSTRY P/E
36.28
EPS (TTM)
7.08
P/C
16.73
PRICE/BOOK
1.98
DIV YIELD.(%)
0.57%
FACE VALUE (Rs)
2.00
DELIVERABLES (%)
38.19 new
DELIVERY AVERAGES
3-Day 36.62%
5-Day 33.80%
8-Day 32.08%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Dishman Pharma on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 31-Aug-2015 (Quarterly Results)
AGM
on 29-Sep-15 (Rs.2.0000 per share(100%)Final Dividend)
Book Closure
From 12-Sep-15 to 29-Sep-15 for Rs.2.0000 per share(100%)Final Dividend
Ex-Dividend
on 10-Sep-2015(Final 100.00%)
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

28 August 2015

buy

ZeeEntertain Aug Fut

Entry Price (Rs)

382.00

Exit Price (Rs)

387.00

Gain (Rs)

5.00

buy

EVEREADY (I) Aug Fut

Entry Price (Rs)

274.00

Exit Price (Rs)

291.00

Gain (Rs)

17.00

buy

Wockhardt Aug Fut

Entry Price (Rs)

1,362.00

Exit Price (Rs)

1,386.00

Gain (Rs)

24.00

buy

PFIZER LTD. Aug Fut

Entry Price (Rs)

2,286.00

Exit Price (Rs)

2,330.00

Gain (Rs)

44.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 155.90 200.05  
High Price 157.30 214.55  
Low Price 150.60 200.05  
Last Price 151.50 209.90 38.55
Volume 205,658 212,521 3.34
Simple Moving Averages
Days BSE NSE
30 198.58 198.76
50 184.47 184.60
150 166.07 166.14
200 157.81 157.85

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Dishman Pharma

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Mar'15 Dec'14 Sep'14
Jun'14
Net Sales 160.06 118.36 109.37 89.67
Other Income 31.02 6.00 24.56 3.90
PBDIT 44.42 41.87 32.15 29.80
Net Profit 22.11 8.04 25.38 1.58

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
Mar'14
(In Rs Cr)
Total Share Capital 16.14
Net Worth 797.08
Total Debt 416.46
Net Block 694.61
Investments 187.06
Total Assets 1,213.55
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 884.95 -2.00 1200.70 821.70 212,962.88
Lupin 1862.70 -1.89 2112.00 1302.00 83,836.77
Dr Reddys Labs 4178.70 1.14 4337.00 2965.00 71,271.04
Cipla 659.75 -0.21 752.45 515.90 52,984.84
Aurobindo Pharm 754.75 1.46 1540.55 409.25 44,074.72
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Jun' 15Mar' 15Dec' 14Sep' 14
Promoter61.4061.4061.4061.40
FII14.7414.5012.7315.13
DII3.473.903.743.73
Others20.3920.2022.1319.74
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Bhadr - Raj Chambers, Swastik Cross Road,,Navrangpura.
City
Ahmedabad
State
Gujarat
Pin Code
380009
Tel. No.
079-26443053 079-26445807
Fax No.
079-26420198
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-13, Pannalal Silk Mills Compound, LBS Marg, Bhandup (W)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25963838, 25946970
Fax No.
022-25946969
MANAGEMENT
Name
Designation
Janmejay R Vyas
Chairman & Managing Director
Arpit J Vyas
Managing Director
Sanjay S Majmudar
Director
Ashok C Gandhi
Director
Deohooti J Vyas
Whole Time Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Zensar Technologies Recommended on Mar 24th 2015

Recommended price 623.00  |  Peak from reco 1011.00 62.28%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Dishman Pharma

Dishman Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,693.83 crore.

The company management includes Janmejay R Vyas - Chairman & Managing Director, Arpit J Vyas - Managing Director, Sanjay S Majmudar - Director, Ashok C Gandhi - Director, Deohooti J Vyas - Whole Time Director, Mark Griffiths - Additional Director, Subir Kumar Das - Additional Director, Rajendra S Shah - Addnl. & Ind.Director.

It is listed on the BSE with a BSE Code of 532526 and the NSE with an NSE Code of DISHMAN.

Its Registered office is at Bhadr - Raj Chambers, Swastik Cross Road,,Navrangpura. Ahmedabad,Gujarat - 380009.

Their Registrars are Link Intime India Pvt. Ltd.

Quick Links for Dishman Pharmaceuticals & Chemicals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Dishman Pharma